Kamil Nikel

Dr. Kamil Nikel

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
KNKamil Nikel
Kamil Nikel
MSMichał Rafał Stojko
Michał Rafał Stojko
JSJoanna Smolarczyk
Joanna Smolarczyk
MPMagdalena Piegza
Magdalena Piegza
The gut microbiota plays a key role in mental health, with growing evidence linking its composition to anxiety and depressive disorders. Research on this topic has expanded significantly in recent years. This review explores alterations in the gut microbiota of individuals with anxiety disorders and examines the potential therapeutic effects of probiotics. Background/Objectives: This review aims to analyze the alterations in gut microbiota composition in individuals with anxiety disorders and evaluate the potential therapeutic effects of probiotics in mitigating symptoms. By examining recent research, this study seeks to highlight the gut–brain connection and its implications for mental health interventions. Materials and Methods: A literature search was conducted in PubMed, Embase, CINAHL, and Google Scholar, focusing on studies investigating the relationship between gut microbiota and anxiety disorders, as well as the impact of probiotics on symptom severity. Results: The reviewed studies suggest that individuals with anxiety disorders often exhibit gut microbiota alterations, including reduced microbial diversity and a lower abundance of short-chain fatty acid-producing bacteria. Additionally, probiotics, particularly those from the Lactobacillus genus, may help alleviate anxiety symptoms by modulating gut microbiota composition. Conclusions: Gut dysbiosis appears to be closely linked to anxiety disorders, and probiotic interventions could represent a promising therapeutic avenue. However, further research is needed to clarify underlying mechanisms and optimize treatment strategies.

28 June 2024 in Life
Verified
Journal Article
Open access
PDF file
PPPatrycja Piłat
Patrycja Piłat
KNKamil Nikel
Kamil Nikel
JSJoanna Smolarczyk
Joanna Smolarczyk
MPMagdalena Piegza
Magdalena Piegza
Schizophrenia is a mental illness characterized by disturbances in the perception of reality, thinking, emotions, and social functioning. This significantly impacts the quality of life of patients and leads to long-term disability. Despite advances in understanding its pathogenesis and treatment, schizophrenia remains a clinical challenge, especially due to the diversity of its symptoms and the complexity of its mechanisms. Schizophrenia is associated with abnormal functioning of the dopaminergic system, disturbances in glutamatergic neurotransmission, and oxidative stress in the brain. In recent years, there has been increasing interest in optimizing the treatment of mental disorders. The potential use of ascorbic acid, or vitamin C, in the therapy of schizophrenia could bring substantial benefits to patients. Ascorbic acid exhibits antioxidant and neuroprotective properties, suggesting its potential efficacy in reducing brain oxidative stress and improving neurotransmission. Additionally, there have been reports of its positive effects on psychotic symptoms and its potential in reducing the side effects of antipsychotic drugs. In this review article, we present the current state of knowledge on the potential use of ascorbic acid in the treatment of schizophrenia as an adjunct to standard pharmacological therapy. We analyze existing clinical studies and the mechanisms of action of vitamin C, suggesting its promising role as an adjunctive therapy in the treatment of schizophrenia. These insights, though not yet widely disseminated, may be significant for the further development of therapeutic strategies for this mental illness.

31 October 2024 in Life
Verified
Journal Article
Open access
PDF file
MSMichał Rafał Stojko
Michał Rafał Stojko
ASAleksandra Spychał
Aleksandra Spychał
KNKamil Nikel
Kamil Nikel
RKRafał Kołodziej
Rafał Kołodziej
JZJolanta Zalejska-Fiolka
Jolanta Zalejska-Fiolka
Background: Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for cardiovascular diseases; however, the impact of fat-based diets on its levels remains unclear. Objective: This study aims to assess and analyze current evidence on the impact of various types of fat-based diets on Lp(a) levels. Material and Methods: A comprehensive search of the PubMed database was conducted on 9 July 2024, focusing on clinical and randomized trials published since 2000. Out of 697 identified studies, 33 met the inclusion criteria and were selected for analysis. Results: The findings suggest that modifications in fat-based diets, particularly concerning the type and amount of consumed fats and fatty acids, can significantly influence plasma Lp(a) levels. Diets rich in unsaturated fats, including polyunsaturated and monounsaturated fatty acids, were associated with more favorable effects in lowering Lp(a) levels. In contrast, diets high in saturated fats were linked to elevated Lp(a) levels. However, these conclusions were not consistent across all studies considered. Conclusions: This work highlights the importance of a personalized dietary approach, considering both genetic predispositions and dietary habits. While diet alone may not drastically alter Lp(a) levels due to their strong genetic determination, a comprehensive strategy involving a healthy diet rich in unsaturated fats, regular physical activity, and effective weight management is recommended to reduce the risk of cardiovascular diseases. Further research is needed to clarify the mechanisms through which different fats affect Lp(a) and to develop targeted dietary recommendations.

5 June 2025 in Ginekologia Polska
Verified
Journal Article
Open access
PDF file
MSMichal Stojko
Michal Stojko
SSSzymon Stojko
Szymon Stojko
NLNatalia Leszczynska
Natalia Leszczynska
KNKamil Nikel
Kamil Nikel
ADAgnieszka Drosdzol-Cop
Agnieszka Drosdzol-Cop
Iatrogenic endometriosis, a rare form of endometriosis resulting from surgical interventions, has become increasingly recognized as a complication of cesarean sections. This study examines the development of clear cell carcinoma (CCC) arising from endometrial tissue implanted in cesarean section scars. Based on a review of 41 clinical cases, the study highlights the challenge in diagnosis and management of this uncommon aggressive malignancy. The average delay from cesarean section to diagnosis was 18 years, with common symptoms being painful masses and scar tenderness. Imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) were the first diagnostic tools, while biopsy confirmed malignancy in most cases. The outlook for patients who had CCC in cesarean scars was extremely poor, and scant long-term survival data existed. These observations serve to reemphasize the necessity of increased awareness by gynecologists and obstetricians of the risk potential associated with cesarean delivery. Improved diagnostic scrutiny, especially in the patient who comes to the doctor with unexplained symptoms involving the scar, is recommended in this study. A strong role is also supported in informed choice before surgical modes of delivery are attempted. Keywords: endometriosis caesarean section clear cell carcinoma

9 June 2025 in Psychiatria i Psychologia Kliniczna
Verified
Journal Article
Open access
KNKamil Nikel
Kamil Nikel
PPPatrycja Piłat
Patrycja Piłat
JSJoanna Smolarczyk
Joanna Smolarczyk
MPMagdalena Piegza
Magdalena Piegza
The sexuality of individuals with intellectual disabilities is a frequently overlooked topic, despite its significant impact on their lives and well-being. This paper presents a systematic review of existing research on this subject, using databases such as PubMed, Embase, and CINAHL. A literature search was conducted, identifying 10,037 studies, ultimately including 24 significant research papers that met the selection criteria, along with 14 supplementary articles. The aim of the review was to explore the issues related to the sexual functioning of individuals with intellectual disabilities, identify the most common barriers and limitations to healthy sexual fulfilment, and highlight the associated risks. The results of the review underscore the need for further research in the area of sexuality of individuals with intellectual disabilities. The analysed articles addressed various issues, such as inadequate sexual education, social and institutional barriers, diversity of needs and experiences, and social stigmatisation. The conclusions point to the necessity for a change in the approach to sexual education, increased social awareness, and the adaptation of support services to the individual needs of people with intellectual disabilities, which can contribute to improving their autonomy, safety, and quality of life. Ongoing research in this field and the implementation of practical actions are essential for the development of a more inclusive and understanding societal approach to the sexuality of individuals with intellectual disabilities. Only through such efforts can full participation of individuals with intellectual disabilities in society be ensured, along with respect for their rights to sexuality and intimacy.

30 July 2026 in Annales Academiae Medicae Silesiensis
Verified
Journal Article
Open access
PDF file
KNKamil Nikel
Kamil Nikel
MSMichał Stojko
Michał Stojko
JCJustyna Chudy
Justyna Chudy
JSJoanna Smolarczyk
Joanna Smolarczyk
Introduction: Depressive disorders are among the leading causes of disability worldwide, and a substantial proportion of patients fail to achieve full remission with standard monoaminergic therapies. Consequently, increasing attention has been directed toward alternative pathophysiological mechanisms, particularly chronic inflammation and oxidative stress. Methods: A narrative review was conducted based on a comprehensive search of PubMed, Scopus, Web of Science, and PsycINFO databases, including studies published between 2000 and 2025. The literature search strategy relied on precise keywords such as "depressive disorders," "chronic inflammation," "oxidative stress," and various "biological biomarkers." The analysis focused on inflammatory markers, oxidative stress parameters, and their association with depressive disorders. To ensure a rigorous study selection process, a two-stage screening strategy was applied, involving an initial evaluation of titles and abstracts followed by a comprehensive full-text review of the shortlisted articles by the authors. Results: Available evidence indicates that patients with depression frequently exhibit elevated levels of pro-inflammatory markers, including interleukin-6, tumor necrosis factor-alpha, and C-reactive protein. Concurrently, increased production of reactive oxygen species and reduced activity of antioxidant enzymes have been observed. These processes are associated with alterations in neurotransmission, activation of the kynurenine pathway, and impaired neuroplasticity, partly mediated by decreased levels of brain-derived neurotrophic factor. Conclusions: Inflammation and oxidative stress appear to represent important components of the pathophysiology of depression, particularly in a subset of patients. Their potential role as biomarkers and therapeutic targets remains promising but requires further validation in well-designed prospective studies, taking into account the clinical heterogeneity of depressive disorders.